Skip to main content
. 2021 Sep 4;5(5):zrab063. doi: 10.1093/bjsopen/zrab063

Table 2.

Operative characteristics

High-dose group (n = 88) Standard-dose group (n = 86)
Major procedure performed 21 (23.9) 23 (26.7)
Primary procedure
 Right/extended right hepatectomy 5 (5.7) 13 (15.0)
 Left hepatectomy 11 (12.5) 6 (7.0)
 Bisegmentectomy 16 (18.2) 14 (16.3)
 Segmentectomy 11 (12.5) 9 (10.5)
 Non-anatomical resection(s) 20 (22.7) 21 (24.4)
 Radiofrequency ablation 8 (9.1) 14 (16.3)
 Exploratory laparotomy 11 (12.5) 4 (4.7)
 Ligation of portal vein 2 (2.3) 2 (2.3)
 Other 4 (4.5) 3 (3.5)
Other procedure(s)
 Cholecystectomy 43 (48.9) 39 (45.3)
 Radiofrequency ablation 19 (21.6) 21 (24.4)
 Segmentectomy 5 (5.7) 1 (1.2)
 Non-anatomical resection(s) 14 (15.9) 14 (16.3)
 Biopsy 5 (5.7) 3 (3.5)
 Other 8 (9.1) 7 (8.1)
Duration of operation (min)* 163.5 (73.6) 161.8(65.7)
Interval from end of operation to extubation (min)* 13.6 (6.9) 14.6(7.7)
Blood loss 503 (216–1173) 568 (203–989)
Abdominal drain 46 (52.3) 41 (47.7)
Blood transfusion 13 (14.8) 10 (11.6)
Hepatic clamping 41 (46.6) 35 (40.7)
Ischaemia time (min) 30 (14.5–52) 28.5 (15–45)

Values in parentheses are percentages unless indicated otherwise; *values are mean(s.d.) and median (i.q.r.). Biopsy (4 patients), colectomy/resection (2), hysterectomy/bilateral salpingo-oophorectomy and colonic resection (1).